Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas - Combined analysis with microdissectionand polymerase chain reaction-single-strand conformation polymorphism
Yc. Dai et al., Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas - Combined analysis with microdissectionand polymerase chain reaction-single-strand conformation polymorphism, CANC CYTOP, 90(4), 2000, pp. 258-263
BAGKGROUND. Cytologic specimens are one of the most important materials for
lung carcinoma diagnosis, because they can be used in mass screening for l
ung carcinoma and early detection of cancer recurrence by examination of sp
utum and pleural fluid.
METHODS. To prove the potentiality of the cytologic specimens to be subject
ed to molecular detection of recurrent lung carcinomas, the authors enrolle
d 16 patients who had undergone surgical treatment for lung carcinoma with
recurrence detected by malignant pleural fluid. First, they examined K-ras
gene and p53 tumor suppressor gene abnormalities in resected tumors by poly
merase chain reaction-based single-strand conformation polymorphism (PCR-SS
CP) analysis. Next, using a microdissection method, they investigated the u
se of cytologic specimens such as pleural fluid for the detection of recurr
ence by finding the same mutations observed in the initially resected tumor
.
RESULTS. Seven abnormally shifted bands were detected among six patients by
PCR-SSCP analysis of surgical materials. Five of 7 abnormally shifted band
s (71.4%) also were detected from microdissected malignant cells in cytolog
ic smears. In two cases, they detected mutations by using single malignant
cells in pleural fluid.
CONCLUSIONS. The authors successfully detected the same mutations in recurr
ent cytologic specimens as those in the initially resected tumors by PCR-SS
CP analysis. These findings suggest that the p53 and K-ras gene mutation pa
tterns are effective markers for the detection of recurrent lung carcinoma
in cytologic specimens. Cancer (Cancer Cytopathol) 2000;90:258-63. (C) 2000
American Cancer Society.